Meeting of the Uniform Formulary Beneficiary Advisory Panel, 49653-49654 [E8-19503]

Download as PDF 49653 Federal Register / Vol. 73, No. 164 / Friday, August 22, 2008 / Notices DEPARTMENT OF DEFENSE Office of the Secretary Strategic Environmental Research and Development Program, Scientific Advisory Board Department of Defense. Notice. AGENCY: ACTION: SUMMARY: This Notice is published in accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463). The topic of the meeting on September 9–11, 2008 are to review new start and continuing research and development projects requesting Strategic Environmental Research and Development Program funds in excess of $1M. This meeting is open to the public. Any interested person may attend, appear before, or file statements with the Scientific Advisory Board at the time and in the manner permitted by the Board. DATES: Tuesday, September 9, 2008, from 9 a.m. to 5 p.m.; Wednesday, September 10, 2008, from 9 a.m. to 5 p.m.; and Thursday, September 11, 2008, from 8:30 a.m. to 4 p.m. ADDRESSES: SERDP Office Conference Center, 901 North Stuart Street, Suite 804, Arlington, VA 22203. FOR FURTHER INFORMATION CONTACT: Mr. Jonathan Bunger, SERDP Office, 901 North Stuart Street, Suite 303, Arlington, VA 22203, telephone (703) 696–2126. Dated: August 15, 2008. Patricia L. Toppings, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. E8–19497 Filed 8–21–08; 8:45 am] BILLING CODE 5001–06–P ACTION: Notice of meeting; Amendment. SUMMARY: On August 11, 2008 (73 FR 46605), the Department of Defense announced a closed meeting of the U.S. Nuclear Command and Control System Comprehensive Review Advisory Committee. This notice is being published to announce changes in the time, location and agenda of the meeting. September 3, 2008 (0830–1700) and September 4, 2008 (0800–1730). DATES: U.S. Strategic Command Headquarters Conference Room, Offutt AFB, NB. ADDRESSES: Mr. William L. Jones, (703) 681–8681, U.S. Nuclear Command and Control System Support Staff (NSS), Skyline 3, 5201 Leesburg Pike, Suite 500, Falls Church, VA 22041. FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF DEFENSE Office of the Secretary U.S. Nuclear Command and Control System Comprehensive Review Advisory Committee AGENCY: Department of Defense. SUPPLEMENTARY INFORMATION: Agenda: Sep 3, 2008: Offutt AFB/HQ USSTRATCOM—Force Execution Time Topic Presenter 8:30 a.m. .................................. 9:30 a.m. .................................. 10 a.m. .................................... 10:30 a.m. ............................... 11:30 a.m. ............................... 1 p.m. ....................................... 2 p.m. ....................................... 3 p.m. ....................................... 4 p.m. ....................................... 5 p.m. ....................................... NMCS Capabilities Brief ........................................................................................................... NMCS Roadmap ...................................................................................................................... Nuclear Forces Connectivity (DC2N concept, Thin-line funding and projected capabilities) .. Oversight of NCCS Assets ....................................................................................................... Lunch ........................................................................................................................................ Tour GOC, Air Room ............................................................................................................... Briefing on OPLAN ................................................................................................................... DOD Exercise Results ............................................................................................................. Executive Session. Adjourn. Joint Staff Joint Staff/USAF OASD (NII)/DISA OASD (NII) Club STRATCOM USSTRATCOM JS/STRATCOM Agenda: Sep 4, 2008: Offutt AFB/HQ USSTRATCOM—Force Execution Time Topic 8 a.m. ............................. 9 a.m. ............................. 10:30 a.m. ...................... Tour NMCS aircraft, get capabilities brief ........................................................................................... NATO NC2 Capabilities & Procedures ............................................................................................... Integrated Tactical Warning/Attack Assessment (Modernization Plans, C2 Plans, issues, capabilities gaps). Communication Satellite Transition Plans ........................................................................................... Lunch. Nuclear Technical Performance Criteria (NTPC) ................................................................................ National Military Command System .................................................................................................... POLO Hat Program (results/trends) .................................................................................................... Executive Session. Adjourn. jlentini on PROD1PC65 with NOTICES 11:30 a.m. ...................... 12 p.m. ........................... 1 p.m. ............................. 3 p.m. ............................. 4 p.m. ............................. 5 p.m. ............................. 5:30 p.m. ........................ Dated: August 13, 2008. Patricia L. Toppings, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. E8–19498 Filed 8–21–08; 8:45 am] Presenter Notice of meeting. Office of the Secretary SUMMARY: Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended) and the Sunshine in the Government Act of 1976 (U.S.C. 552b, as amended) the Department of Defense announces the following Federal Advisory Committee Meeting of the Uniform Meeting of the Uniform Formulary Beneficiary Advisory Panel Department of Defense, Assistant Secretary of Defense (Health Affairs). Jkt 214001 J Staff by VTC J Staff by VTC2 J Staff by VTC ACTION: AGENCY: 18:11 Aug 21, 2008 Air Staff DEPARTMENT OF DEFENSE BILLING CODE 5001–06–P VerDate Aug<31>2005 Crew EUCOM AFSPC PO 00000 Frm 00012 Fmt 4703 Sfmt 4703 E:\FR\FM\22AUN1.SGM 22AUN1 49654 Federal Register / Vol. 73, No. 164 / Friday, August 22, 2008 / Notices Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel). DATES: September 17, 2008 (8 a.m. to 4 p.m.) ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: LtCol Thomas Bacon, Designated Federal Officer, Uniform Formulary Beneficiary Advisory Panel, Skyline 5, Suite 810, 5111 Leesburg Pike, Falls Church, Virginia 22041–3206, Telephone: (703) 681–2890, Fax: (703) 681–1940, e-mail address: baprequests@tma.osd.mil. jlentini on PROD1PC65 with NOTICES SUPPLEMENTARY INFORMATION: Purpose of Meeting: The Panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics (P&T) Committee regarding the Uniform Formulary. Meeting Agenda: Sign-In; Welcome and Opening Remarks; Public Citizen Comments; Scheduled Therapeutic Class Reviews—Self-Monitoring Blood Glucose Systems (meters and strips); Overactive Bladder Agents; Designated Newly Approved Drugs; Panel Discussions and Vote, and comments following each therapeutic class review. Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165, and the availability of space this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly. Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.155, the Department of Defense has determined that the Administrative Work Meeting (to be held prior to the public meeting) shall be closed to the public. The Under Secretary of Defense (Personnel and Readiness), in consultation with the Office of the DoD General Counsel, has determined in writing that the public interest requires that all or part of this meeting be closed to the public because they will be concerned with matters listed in Section 552b(c)(1) of title 5, United States Code. Prior to the public meeting the Panel will conduct an Administrative Work Meeting from 7 a.m. to 7:50 a.m. to discuss administrative matters of the Panel. The Administrative Work Meeting will be held at the Naval Heritage Center Conference Room, 701 Pennsylvania Avenue, NW., Washington D.C. 20004. Pursuant to 41 CFR 102– 3.160, the Administrative Work Meeting will be closed to the public. VerDate Aug<31>2005 17:12 Aug 21, 2008 Jkt 214001 Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140, the public or interested organizations may submit written statements to the membership of the Panel at any time or in response to the stated agenda of a planned meeting. Written statements should be submitted to the Panel’s Designated Federal Officer; the Designated Federal Officer’s contact information can be obtained from the GSA’s FACA Database—https:// www.fido.gov/facadatabase/public.asp. Written statements that do not pertain to the scheduled meeting of the Panel may be submitted at any time. However, if individual comments pertain to a specific topic being discussed at a planned meeting then these statements must be submitted no later than five (5) business days prior to the meeting in question. The Designated Federal Officer will review all submitted written statements and provide copies to all the committee members. Oral Public Comments: In addition to written statements, the Panel will set aside one (1) hour for individuals or interested groups to address the Panel. To ensure consideration of their comments, individuals and interested groups should submit written statements as outlined in this notice, but if they still want to address the Panel then they will be afforded the opportunity to register to address the Panel. The Panel’s Designated Federal Officer will have a ‘‘Sign Up Roster’’ available at the Panel meeting for registration on a first-come, first-serve basis. Those wishing to address the Panel will be given no more than five (5) minutes to present their comments, and at the end of the one (1) hour time period no further public comments will be accepted. Anyone who signs up to address the Panel but is unable to do so due to the time limitation may submit their comments in writing; however, they must understand that their written comments may not be reviewed prior to the Panel’s deliberation. Accordingly, the Panel recommends that individuals and interested groups consider submitting written statements instead of addressing the Panel. Dated: August 15, 2008. Patricia L. Toppings, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. E8–19503 Filed 8–21–08; 8:45 am] BILLING CODE 5001–06–P PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 DEPARTMENT OF DEFENSE Office of the Secretary [Docket ID: DOD–2008–OS–0089] Privacy Act of 1974; System of Records AGENCY: Office of the Inspector General, DoD. ACTION: Notice to amend two systems of records. SUMMARY: The Office of the Inspector General (OIG) is amending two systems of records notices in its existing inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended. DATES: This proposed action will be effective without further notice on September 22, 2008 unless comments are received which result in a contrary determination. ADDRESSES: Send comments to Chief, FOIA/PA Office, Inspector General, Department of Defense, 400 Army Navy Drive, Room 201, Arlington, VA 22202– 4704. FOR FURTHER INFORMATION CONTACT: Mr. Keith Mastromichalis at (703) 604–8723. SUPPLEMENTARY INFORMATION: The Office of the Inspector General (OIG) systems of records notices subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended, have been published in the Federal Register and are available from the address above. The specific changes to the records systems being amended are set forth below followed by the notice, as amended, published in its entirety. The proposed amendments are not within the purview of subsection (r) of the Privacy Act of 1974 (5 U.S.C. 552a), as amended, which requires the submission of a new or altered system report. Dated: August 15, 2008. Patricia Toppings, Federal Register Liaison Officer, Department of Defense. CIG–9 SYSTEM NAME: Security Management and Access Files (May 9, 2003, 68 FR 24932). CHANGES: * * * * * SYSTEM NAME: Delete entry and replace with ‘‘Automated Security Administration System Records.’’ * * * * * E:\FR\FM\22AUN1.SGM 22AUN1

Agencies

[Federal Register Volume 73, Number 164 (Friday, August 22, 2008)]
[Notices]
[Pages 49653-49654]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-19503]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Under the provisions of the Federal Advisory Committee Act of 
1972 (5 U.S.C., Appendix, as amended) and the Sunshine in the 
Government Act of 1976 (U.S.C. 552b, as amended) the Department of 
Defense announces the following Federal Advisory Committee Meeting of 
the Uniform

[[Page 49654]]

Formulary Beneficiary Advisory Panel (hereafter referred to as the 
Panel).

DATES: September 17, 2008 (8 a.m. to 4 p.m.)

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: LtCol Thomas Bacon, Designated Federal 
Officer, Uniform Formulary Beneficiary Advisory Panel, Skyline 5, Suite 
810, 5111 Leesburg Pike, Falls Church, Virginia 22041-3206, Telephone: 
(703) 681-2890, Fax: (703) 681-1940, e-mail address: 
baprequests@tma.osd.mil.

SUPPLEMENTARY INFORMATION:
    Purpose of Meeting: The Panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics (P&T) Committee regarding the Uniform 
Formulary.
    Meeting Agenda: Sign-In; Welcome and Opening Remarks; Public 
Citizen Comments; Scheduled Therapeutic Class Reviews--Self-Monitoring 
Blood Glucose Systems (meters and strips); Overactive Bladder Agents; 
Designated Newly Approved Drugs; Panel Discussions and Vote, and 
comments following each therapeutic class review.
    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 CFR 102-3.140 through 102-3.165, and the availability of space this 
meeting is open to the public. Seating is limited and will be provided 
only to the first 220 people signing in. All persons must sign in 
legibly.
    Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.155, the 
Department of Defense has determined that the Administrative Work 
Meeting (to be held prior to the public meeting) shall be closed to the 
public. The Under Secretary of Defense (Personnel and Readiness), in 
consultation with the Office of the DoD General Counsel, has determined 
in writing that the public interest requires that all or part of this 
meeting be closed to the public because they will be concerned with 
matters listed in Section 552b(c)(1) of title 5, United States Code.
    Prior to the public meeting the Panel will conduct an 
Administrative Work Meeting from 7 a.m. to 7:50 a.m. to discuss 
administrative matters of the Panel. The Administrative Work Meeting 
will be held at the Naval Heritage Center Conference Room, 701 
Pennsylvania Avenue, NW., Washington D.C. 20004. Pursuant to 41 CFR 
102-3.160, the Administrative Work Meeting will be closed to the 
public.
    Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-3.140, 
the public or interested organizations may submit written statements to 
the membership of the Panel at any time or in response to the stated 
agenda of a planned meeting. Written statements should be submitted to 
the Panel's Designated Federal Officer; the Designated Federal 
Officer's contact information can be obtained from the GSA's FACA 
Database--https://www.fido.gov/facadatabase/public.asp.
    Written statements that do not pertain to the scheduled meeting of 
the Panel may be submitted at any time. However, if individual comments 
pertain to a specific topic being discussed at a planned meeting then 
these statements must be submitted no later than five (5) business days 
prior to the meeting in question. The Designated Federal Officer will 
review all submitted written statements and provide copies to all the 
committee members.
    Oral Public Comments: In addition to written statements, the Panel 
will set aside one (1) hour for individuals or interested groups to 
address the Panel. To ensure consideration of their comments, 
individuals and interested groups should submit written statements as 
outlined in this notice, but if they still want to address the Panel 
then they will be afforded the opportunity to register to address the 
Panel. The Panel's Designated Federal Officer will have a ``Sign Up 
Roster'' available at the Panel meeting for registration on a first-
come, first-serve basis. Those wishing to address the Panel will be 
given no more than five (5) minutes to present their comments, and at 
the end of the one (1) hour time period no further public comments will 
be accepted. Anyone who signs up to address the Panel but is unable to 
do so due to the time limitation may submit their comments in writing; 
however, they must understand that their written comments may not be 
reviewed prior to the Panel's deliberation. Accordingly, the Panel 
recommends that individuals and interested groups consider submitting 
written statements instead of addressing the Panel.

    Dated: August 15, 2008.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
 [FR Doc. E8-19503 Filed 8-21-08; 8:45 am]
BILLING CODE 5001-06-P